Categories: Business

NYSE Content Advisory: Annual International Day Slate Announced

NEW YORK, Sept. 18, 2025 /PRNewswire/ — The New York Stock Exchange will hold the 2nd annual NYSE International Day, on October 23, 2025, celebrating global business excellence and fostering cross-border innovation and investment. The event is designed to bring together C-suite executives of international innovators, PE/VC investors, and the NYSE listed community for a half-day of insightful discussions, networking, and product showcases, followed by a networking reception on the Trading Floor.

- Advertisement -

International companies from regions including Canada, UK/Europe, MEA, APAC and Latin America will showcase products and innovations during networking breaks. Scheduled sessions will include discussions on the future of fintech, scaling businesses beyond borders globally, future mobility innovations, exit strategies balancing M&A and IPOs, and bridging private and public markets for late-stage companies.

- Advertisement -

Announced speakers include:

- Advertisement -
  • Jim Cramer, CNBC host, who will deliver the Opening Keynote interview alongside NYSE President Lynn Martin
  • Scarlett Sieber, Chief Strategy & Growth Officer, Money20/20
  • Frederik Thomasen, Head of Equity Capital Markets, Norges Bank Investment Management (NBIM)
  • Anu Aiyengar, Managing Director, Global Head of Advisory and Mergers & Acquisitions, J.P. Morgan
  • Masaki (Mory) Morimoto, President, The House of Suntory
  • Wen Han, Founder, Chairman & CEO, Windrose Technology

Click here to REGISTER and learn more about NYSE International Day

- Advertisement -

Photo – https://mma.prnewswire.com/media/2774646/NYSE_Annual_International_Day_Slate_Announced.jpg

- Advertisement -

Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

2 weeks ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

3 weeks ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

3 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

4 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

2 months ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

2 months ago